Concepedia

Natarajan Muthusamy

NM

Statistics

Publications

111

Citations

9.6K

H-Index

51

Active since

1988

Affiliations

The Ohio State University(Current)

University of Kentucky

Markey Cancer Center

American Association of Colleges of Pharmacy

Natarajan Muthusamy is an author at The Ohio State University specializing in life sciences, oncology, and immunology.

ORCID

Publications per year

1988–2024

111

Publications

111

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 796 citations

, , +14

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

Ramiro Garzon, Shujun Liu, Muller Fabbri et al. · Blood · 2009 · 774 citations · Full text

, , +16

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

Joseph A. Fraietta, Kyle A. Beckwith, Prachi Patel et al. · Blood · 2016 · 461 citations · Full text

, , +12

Ibrutinib treatment improves T cell number and function in CLL patients

Meixiao Long, Kyle A. Beckwith, Priscilla Do et al. · Journal of Clinical Investigation · 2017 · 377 citations · Full text

, , +17

The Ets-1 Transcription Factor Is Required for the Development of Natural Killer Cells in Mice

Kevin Barton, Natarajan Muthusamy, Christopher Fischer et al. · Immunity · 1998 · 355 citations · Full text

, , +14

1–5 of 111